Background: Monitoring of fruit and vegetable (F&V) intake is fraught with difficulties. Available dietary assessment methods are
Introduction
Increased fruit and vegetable (F&V) 11 intake may prevent or reduce the risk of many chronic diseases (1), including cardiovascular diseases (CVDs) (2) and certain cancers (3) . The beneficial effects of these foods have been attributed to a wide range of bioactive components, including carotenoids, vitamin C, flavonoids, and folic acid (4) (5) (6) , although the relative contribution of each is unclear. Thus, there is a rationale for conducting robust randomized controlled trials to establish dose-response relations between specific fruits and vegetables and their constituents and specific health outcomes.
When studying the relation between diet composition, physiologic status, and disease risk, reliable and valid methods for dietary assessment are essential. Traditionally, methods of assessing dietary intake have been subjective, with the use of tools such as food diaries, FFQs, and 24-h recall. Substantial errors are associated with portion-size estimation, inaccurate recall, and incomplete and erroneous food composition databases (7) . Given this continuing problem with unreliability of dietary methods, it is timely to investigate the use of biomarkers of F&V consumption, which could provide an alternative and more objective measure of compliance to intervention and habitual intake. Such methods should be sensitive to variations in the quantity and variety of F&V intake.
Plasma biomarkers such as vitamin C (8) and carotenoids (9) have been used to validate F&V intake data obtained from dietary assessment in habitual diet studies (7, 10) . These biomarkers were also used to assess compliance of free-living volunteers required to increase F&V intake in dietary interventions (11, 12) . However, no studies to date have examined the use of a combination of plasma biomarkers to monitor or predict F&V intake by volunteers. Literature reports vary in their assessment of the relative usefulness of vitamin C and carotenoids as plasma biomarkers of F&V intake. Most studies found that the concentration of plasma carotenoids is a reasonable biomarker of dietary intake of F&Vs (10, (13) (14) (15) . Plasma concentrations of carotenoids were reported to be more responsive to increases in F&V intake than those of vitamin C (16) , although the degree of association could also depend on the types of F&Vs consumed. In 1 prospective cohort study, plasma vitamin C concentration was more strongly associated with F&V intake than either plasma carotenoids or vitamin E (17) . In Western diets, F&V consumption is the main source of vitamin C and carotenoids (18) . Both biomarkers have limitations; vitamin C in plasma reaches saturation at ;85 mmol/ L (19) and the bioavailability of carotenoids varies widely, being influenced by various factors including food processing and composition. Increased consumption of F&Vs enhances the antioxidant capacity of plasma, and the ferric reducing antioxidant power (FRAP) is 1 method that can be used to monitor this (20, 21 ). Yet, this positive effect of F&V intake on the FRAP value was not observed in all intervention studies (22) (23) (24) . Plasma FRAP depends on contributions from a range of dietary antioxidants and their metabolites, but endogenous antioxidants, especially uric acid, also contribute, and as a result FRAP may be insensitive to modest changes in F&V-derived antioxidant intake (25) .
The sensitivity and usefulness of individual biomarkers are variable and depend on the types of F&Vs consumed, the overall composition of the diet, and a range of physiologic variables. Inconsistent findings in relation to the use of individual biomarkers for predicting F&V intake raise the question of whether a combination of plasma biomarkers, as an integrated biomarker, would give a better correlation with F&V intake than each of the single biomarkers in isolation. So far, no studies have addressed this question.
The current study used data derived from a randomized, controlled, parallel dietary intervention study [the FLAVURS (Flavonoids University of Reading Study) study] (26), which included a control (CT) group and 2 intervention groups. The participants who were randomly assigned to the 2 intervention groups had sequential increases in their F&V consumption across an 18-wk period, with increases in number of portions at 3 time points. The 2 intervention groups consumed flavonoid-rich and flavonoid-poor F&Vs, respectively. The total carotenoid contents of diets of the 2 intervention groups were matched as closely as possible.
Data from this study were analyzed to investigate the potential benefits of using the sum (and adjusted sum) of plasma concentrations of vitamin C and cholesterol-adjusted carotenoids, urinary concentrations of potassium, and the plasma FRAP value as an integrated biomarker of F&V intake. The correlation between the integrated biomarker and number of portions of F&Vs consumed was compared with each individual biomarker of F&V intake (plasma vitamin C, plasma carotenoids, urinary potassium, and plasma FRAP values). Also, the power of each single biomarker and the integrated biomarker to predict F&V intake was assessed and compared. Urinary flavonoid concentrations were also monitored as a biomarker of F&V intake but were not used in the development of an integrated biomarker for all F&Vs because there was no significant increase for volunteers consuming the flavonoidpoor F&Vs (27) .
Participants and Methods
Participants. Details of participant recruitment are given in Chong et al. (26) . A total of 174 participants with a 1.5-fold increased risk of CVD, assessed by using a scoring system adapted from the Framingham CVD risk scoring tool (26) , were recruited; and 154 (89%; 60 men and 94 women) aged between 30-70 y completed the dietary intervention study.
The study protocol was approved by the Local Research Ethics Committee of the Isle of Wight, Portsmouth and South East Hampshire (Research Ethics Committee number: 07/H0501/81), and the University of ReadingÕs Research Ethics Committee. All participants gave informed consent before taking part in the dietary intervention study. The study was registered at www.controlled-trials.com as ISRCTN47748735 and was conducted according to the guidelines laid down in the Declaration of Helsinki.
Study design. The study was a parallel, randomized controlled design with sequential dose-response increases in F&V consumption. By using a 5% level of significance, a power of 80%, an intergroup difference of 20% in vascular reactivity (a clinically significant difference in vascular reactivity), and a standardized difference of 0.56, we estimated that a sample size of 51 per group for each of the 3 groups would be required to distinguish between the control and high-or low-flavonoid (HF and LF, respectively) consumers. Participants were recruited according to specific inclusion and exclusion criteria described in detail previously (26, 27) , which included consumption of lower than population mean intakes of F&Vs and no use of dietary supplements. Participants were randomly assigned to either a CT group or 1 of 2 intervention groups: HF or LF groups. All 3 groups were encouraged to continue with their background habitual diet.
After a 2-wk run-in period during which participants made no dietary changes, the CT group continued to consume their habitual diet throughout the 18-wk study, whereas the HF and LF groups sequentially increased their daily F&V intake by 2 extra portions/d every 6 wk of the study to a maximum of 6 extra portions with flavonoid-rich and flavonoid-poor F&Vs, respectively. A portion of fruits or vegetables was equivalent to 80 g (40 g for dried foods) in weight as specified by UK guidelines (28) . Fresh F&Vs were delivered to participants on a weekly basis. Details of the study are given in Chong et al. (26) . For this study, data from volunteers consuming LF and HF F&Vs were combined with those of the CT group to allow assessment of the usefulness of the plasma biomarkers in predicting number of F&V portions consumed.
Sample collection. Fasted blood samples were collected by venipuncture at baseline and at each visit into vacuum lithium heparin, serum citrate, and EDTA-coated tubes (Greiner Bio-One). The blood samples were cooled on ice, and plasma was separated by centrifugation at 1560 g for 10 min at 4°C, transferred into cryogenic vials, and stored at 280°C. Plasma samples for vitamin C analysis were mixed with an equal volume of 5% metaphosphoric acid and centrifuged at 24,960 g for 10 min, and the supernatant was transferred into vials and stored at 280°C until analysis. Twenty-four-hour urine samples were collected in pots containing hydrochloric acid (;1%) as a preservative. Immediately after each urine sample was brought into the Hugh Sinclair Unit of Human Nutrition, urine volumes were measured and recorded and a sample was transferred into 15-mL Falcon tube (Fisher Scientific) and centrifuged at 1560 g at 4°C before storage at 220°C.
Plasma ascorbic acid and plasma carotenoids. Stored plasma samples treated as described above were mixed with ammonium dihydrogenphosphate buffer (20 mmol/L) containing meta-phosphoric acid (0.15%) (1:1) before analysis of ascorbic acid. The solution was then analyzed by HPLC by using a Nucleosil C18 column (250 3 4.6 mm i.d.; Hichrom) with isocratic elution with ammonium dihydrogenphosphate buffer (20 mmol/L) containing metaphosphoric acid (0.15%). Detection was at 245 nm. Details are provided in George et al. (29) .
Carotenoids were extracted into n-heptane and analyzed by HPLC by using a Spherisorb ODS-2 column (100 mm 3 4.6 mm i.d.; Phenomenex) and isocratic elution with acetonitrile:methanol:chloroform (47:47:6) as described in George et al. (29) . Plasma total carotenoid concentrations (mmol/L) were divided by plasma cholesterol concentrations and are reported as plasma total carotenoid concentrations (mmol/mol) throughout this article.
Urinary potassium. Urine samples were diluted with de-ionized water (1:1200). Caesium chloride (CsCl) was added to diluted samples and standards with a total concentration of 0.5% (0.04 mol/L) wt:v, and potassium was measured at 766.5 nm (Association of Official Analytical Chemists official method for detection of minerals: number 985.35) by using the Atomic Absorption Spectrometer novAA-350 (Analytikjena UK) with WinAAS software version 4.5.0.
FRAP of plasma. Plasma FRAP was determined according to Bub et al. (30).
Measures of compliance and dietary assessment. To monitor compliance, random 24-h dietary recalls were recorded with a minimum of 8 recalls per participant (minimum of 2 recalls at baseline during weeks 0-6, 6-12, and [12] [13] [14] [15] [16] [17] [18] . From the 24-h dietary recalls, compliance to the additional portions of F&Vs consumed was determined by subtracting baseline F&V intake from the total number of portions of F&Vs consumed by the participants at intervals throughout the study. Volunteers were also asked to complete food record sheets. Full details of dietary assessment are given in Chong et al. (26) . In this article, the total number of F&V portions determined by the 24-h dietary recalls was used for all statistical analyses.
Statistical analysis. All correlations were analyzed by the Pearson test with the use of SPSS 19.0 for Microsoft Windows. The data were checked for normality by using the Kolmogorov-Smirnov test. Data that were not normally distributed were square-root transformed and reassessed. For assessing the predictive power of plasma biomarkers for F&V intake, combined data of 3 groups (i.e., 2 intervention groups and a CT group) on visit 4 were used to set up the model, because this time point would represent the widest spread of F&V intake and plasma concentrations of biomarkers. Minitab 16.0 and SPSS 19.0 for Microsoft Windows were used for setting up the model. Plasma total carotenoid concentrations (mmol/mol) were used for regression analysis and for calculating the predicted values of F&V portions, and these were all square-root transformed. Initially, regression analysis was undertaken to determine the correlation between the number of F&V portions and concentrations of plasma carotenoids at visit 4 by using Minitab 16.0, and a regression equation was generated. The residues between the observed (original) values of F&V portions and the fitted (predicted) values of F&V portions were calculated. This regression equation at visit 4 was thereafter used to calculate the predicted values of F&V portions at the other 3 visits by inserting the concentrations of plasma carotenoids 
The magnitude of the error in predictions was assessed by the standardized normal deviate of residues from the mean. All of the calculated residues were transformed to positive values. The standardized normal deviate of each residue from the mean was then calculated across all visits, converted to positive values, and used for a paired-sample t test for each visit to determine whether the integrated biomarker was superior to the plasma carotenoid concentration for predicting the number of portions of F&Vs consumed across 4 visits. The significance level was set at 0.05 for all data, and data are reported as means 6 SEMs.
Results
The baseline characteristics of FLAVURS participants reported in this study (n = 154) are shown in Table 1 . The number of F&V portions consumed by the supplemented volunteers reached 7.8-8.1 portions/d compared with 4.6 portions/d for the CT group (P < 0.001), which provided a sufficiently wide range of intakes for this study ( Table 2) . Plasma vitamin C and total carotenoid concentrations and FRAP values were also significantly higher for the F&V-supplemented volunteers than for the controls (P < 0.01) (26, 27) . b-Carotene and lycopene were the major carotenoids in plasma, with a-carotene, lutein, and b-cryptoxanthin present at lower concentrations ( Table 3) . Because this article focuses on the combined values of plasma biomarkers from both intervention groups and the CT group, for each biomarker at each visit, the data from all groups were pooled ( Table 2 ). The plasma FRAP values and vitamin C and carotenoid contents all increased significantly during the intervention (P < 0.001, P < 0.001, and P = 0.047, respectively). An integrated biomarker corresponding to the sum of plasma vitamin C and total carotenoid concentrations and FRAP values without any multiplying factors did not improve on plasma carotenoid concentration as a biomarker. The general linear model with univariate analysis in SPSS 19.0 was used to develop a regression model that included all 3 biomarkers with their corresponding parameter estimates that were significant (P < 0.05), the sum of which was then used to generate the integrated biomarker. The correlation between F&V portions consumed and plasma integrated biomarker corresponding to the adjusted sum of plasma FRAP, vitamin C, and total carotenoids at visit 4 was higher than that with any of the 3 individual biomarkers ( Table 4) . The correlations between F&V intake and plasma biomarkers including vitamin C, total cholesterol-adjusted carotenoids, and integrated biomarkers at visits 1, 2, and 3 were all lower than those at visit 4, respectively (Table 4) . Repeating the correlation between F&Vs consumed and the integrated biomarker including only those participants with a plasma vitamin C concentration <85 mmol/L had very little effect on the correlation coefficient, which changed from 0.47 (P < 0.001) to 0.48 (P < 0.001) at visit 4 when this group was removed. The analysis of the standardized normal deviate of residues from the mean showed that the difference in predictive power of the 2 biomarkers for F&V intake only reached significance at visit 2 (P < 0.001), with a tendency to be significant at visit 1 (P = 0.07) ( Table 5 ). The percentage of volunteers whose consumption of F&Vs was accurately predicted to within 2 portions only increased from a mean of 47.9 6 5.8% with the use of plasma total cholesterol-adjusted carotenoids to 53.8 6 2.9% with the use of the integrated biomarker. The intake of most volunteers could be predicted to 63 portions, with 66.7 6 5.3% predicted correctly by plasma total carotenoids and 72.4 6 2.6% predicted correctly by the integrated biomarker. The inclusion of urinary potassium (Table  2) in the integrated biomarker did not improve the correlation at any of the visits (data not shown), so this variable was not studied further.
Discussion
Previous studies have investigated the use of plasma carotenoids or vitamin C as biomarkers of F&V intake. This study is the first, to our knowledge, to test whether a novel combined biomarker can be developed that provides a more ''robust'' measure of habitual intake or compliance to an F&V-based intervention.
There are a number of factors that limit the use of individual biomarkers for the prediction of F&V intake. The wide variation in content of phytochemicals between different types of F&Vs or different varieties of the same F&V has a big effect on the efficacy of any individual biomarker. In an investigation of 34 types of F&Vs, Szeto et al. (31) reported an 18-fold variation in FRAP value and a 27-fold variation in vitamin C per unit weight, with vitamin C contributing from <1% to 73% of the FRAP value. The carotenoid content of F&Vs also varies over a wide range (32) , and in some cases, foods with a very low carotenoid content [e.g., strawberries (0.025 mg/100 g)] contain a higher content of vitamin C than do foods with a much higher carotenoid content [e.g., oranges (0.399 mg/100 g)]. Thus, on the basis of the content in the raw F&Vs alone, the correlation between number of portions of F&Vs consumed and an individual plasma biomarker is expected to be limited. However, various other factors also limit the usefulness of individual biomarkers. These include interindividual variation in digestion, absorption, and metabolism associated with genetic variation and environmental factors. Perez-Galvez et al. (33) reported 2 patterns of absorption after acute ingestion of carotenoids, with carotenoid concentrations in the TG-rich lipoprotein fraction of responders increasing by >6 times that in the nonresponders. In addition to these factors, the resistance to change or loss of food components during processing, their bioavailability, and the response of the biomarker to dietary intake of the component can also affect the efficacy as biomarkers.
Plasma carotenoid concentration was found to be useful as a biomarker of F&V intake, but bioavailability of carotenoids is affected by a number of factors that affect absorption (34) , and plasma carotenoid concentration also depends on the residence time of plasma lipoproteins in the circulation (13) . The vitamin C content of F&Vs varies widely between different types and their specific growing conditions. In addition, vitamin C concentrations are reduced during processing and storage, and plasma vitamin C concentration does not increase above a limiting value (19) . The plasma FRAP value depends on content, bioavailability, and effects of metabolism on antioxidants, including phytochemicals (35) (36) (37) . Plasma FRAP values were included in the combined biomarker as an indirect measure of the complex mixture of phytochemicals consumed in F&Vs. The phytochemicals contributing to the FRAP value also vary widely between different samples of the same food. For example, it was reported that apples can provide antioxidants equivalent to 270-1140 mg of vitamin C/100 g (38) . The literature reports that the contributions of individual plasma antioxidants to the total plasma FRAP value were estimated as follows: ascorbic acid (15%), a-tocopherol (5%), uric acid (60%), bilirubin (5%), protein including albumin (10%), and others including phenolic compounds (5%) (25) . It is of note that there was no significant change in plasma uric acid concentrations during the FLAVURS intervention with either HF or LF F&V intake (P = 0.87) (26) , and albumin concentration is unlikely to have changed significantly during the intervention, so these components would not have contributed to changes in the FRAP value.
To reduce the impact of the limitations in the individual biomarkers, the integrated biomarker based on all 3 components was studied, which gave an improved correlation compared with the correlations for the individual biomarkers. The rationale behind the use of the integrated biomarker was that it would increase the contribution of a wider range of foods to the biomarker, although it is recognized that vitamin C contributes to the FRAP value as well as the concentration being included directly. The plasma total cholesterol-adjusted carotenoid concentration was the most predictive of the individual biomarkers, which is in agreement with previous findings (10) . The predictive power of the integrated biomarker is clearly driven mainly by the plasma carotenoid concentration. Thus, plasma total cholesterol-adjusted carotenoid concentration or the integrated biomarker can be used to distinguish between most moderateand high-F&V consumers.
Another factor limiting the predictive power of the integrated biomarker is the uncertainty in the number of portions of F&Vs consumed, which was taken from 24-h dietary recall data, which may not reflect the intake accurately. However, in an attempt to gain a representative intake, the recalls were randomly taken on a number of occasions, which reduced the chance of dietary change. The weak correlations with F&V intake for the individual biomarkers were improved only to a limited extent for the integrated biomarker. Because the lower range of intake was 4.6 portions/d for the CT group, it is recognized that it was not demonstrated that the integrated biomarker can be extrapolated to low amounts of F&V intake.
Plasma carotenoid concentration makes a greater contribution than do vitamin C and FRAP values to the integrated biomarker, partly because it is still present in plasma at 12-24 h after the F&Vs have been consumed (39), so differences due to diet are not eliminated by metabolism and excretion to the same extent as for vitamin C and most components contributing to the FRAP value. In addition, the plasma sample was collected after an overnight fast, which may have reduced the measured vitamin C and FRAP values due to loss of the phytochemicals after metabolism and excretion. It has been reported that once the plasma concentration of vitamin C increases >85 mmol/L, the renal transport system is saturated and vitamin C is excreted quantitatively with increasing intake (19) . In this study, 33% of the 154 participants had a plasma concentration of vitamin C >85 mmol/L. The effect of this group on the correlation was considered, but excluding participants with plasma vitamin C concentrations <85 mmol/L did not significantly increase the correlation coefficient.
In conclusion, an integrated plasma biomarker based on plasma vitamin C, total carotenoids, and FRAP values improved the correlation with F&V intake compared with the individual biomarkers. However, the integrated plasma biomarker did not improve significantly on plasma total carotenoids as a biomarker to predict F&V intake across all visits, although this difference did reach significance for data from volunteers at visit 2, with a tendency to be significant at visit 1. Both measures are rather weak as predictive tools. Both the integrated plasma biomarker and plasma total carotenoids could be used to distinguish moderate-and high-F&V consumers. The limited predictive power of the biomarkers is ascribed to natural variability in F&V composition, bioavailability and timing of plasma collection, as well as possible inaccuracies in the recall of number of F&V portions consumed. The improved correlation of the novel integrated biomarker with F&V intake compared with that of plasma total carotenoid concentration was not sufficient to justify recommending the use of this integrated biomarker for predicting the number of portions of F&Vs consumed.
